Cargando…
SCING—Spinal Cord Injury Neuroprotection with Glyburide: a pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute traumatic spinal cord injury in the USA
INTRODUCTION: Acute traumatic spinal cord injury (tSCI) is a devastating neurological disorder with no pharmacological neuroprotective strategy proven effective to date. Progressive haemorrhagic necrosis (PHN) represents an increasingly well-characterised mechanism of secondary injury after tSCI tha...
Autores principales: | Minnema, Amy Janelle, Mehta, A, Boling, Warren W, Schwab, Jan, Simard, J Marc, Farhadi, H Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797422/ https://www.ncbi.nlm.nih.gov/pubmed/31601596 http://dx.doi.org/10.1136/bmjopen-2019-031329 |
Ejemplares similares
-
Pharmacokinetics and safety of oral glyburide in dogs with acute spinal cord injury
por: Jeffery, Nick, et al.
Publicado: (2018) -
Magnetic Resonance Imaging Pilot Study of Intravenous Glyburide in Traumatic Brain Injury
por: Eisenberg, Howard M., et al.
Publicado: (2020) -
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
por: Lamkanfi, Mohamed, et al.
Publicado: (2009) -
Predicting Failure of Glyburide Therapy in Gestational Diabetes
por: Harper, Lorie M., et al.
Publicado: (2016) -
Review of metformin and glyburide in the management of gestational diabetes
por: Carroll, Dana G., et al.
Publicado: (2014)